2004, Consulting and Medical - Primary Care Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2004

Consulting

Medical

Senators to DEA: Consider Treaty Obligations In Marijuana Rescheduling

FDA Law

APRIL 22, 2024

Milgram’s predecessors, and Directors of National Drug Policy urging not to reschedule; the January 2004 letter Democratic state attorneys general pushing for rescheduling to schedule III; and the January 2024 letter from Democratic senators requesting descheduling altogether. Whether DEA believes the U.S.

Manufacturing

Manufacturing Consulting IT Individual

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

FDA Law

JANUARY 12, 2025

FDAs interpretation of several threshold criteria for eligibility (serious condition, available therapy, unmet medical need) will continue to rely upon the 2014 Guidance. Moreover, it was also interesting to see how FDA discussed the concept of unmet medical need in the limited fashion that it did in this new guidance.

Clinic

Clinic Relationship Provider IT

Senators to DEA: Consider Treaty Obligations In Marijuana Rescheduling

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

Stay Connected